Stay updated on Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new release of the page template. This is a technical update with no indicated changes to study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-11T20:17:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.3 to v3.6.4, reflecting a minor backend/update with no visible changes to study content or layout.
    Difference
    0.1%
    Check dated 2026-07-28T14:59:57.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a new site revision label, Revision: v3.6.3, replacing the previous Revision: v3.6.0. This indicates a software update to the site rather than changes to the clinical study information shown on the page.
    Difference
    0.1%
    Check dated 2026-06-30T06:50:38.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The investigators section was updated to include Hiroaki Akamatsu and adjust institution references. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label formatting was updated, and the revision tag changed from v3.5.5 to v3.6.0.
    Difference
    2%
    Check dated 2026-06-16T00:17:14.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, indicating a new site revision. This replaces the previous Revision: v3.5.4 and reflects a minor platform update.
    Difference
    0.1%
    Check dated 2026-06-09T00:48:37.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the page, replacing the previous v3.5.3. This indicates a site software/version update for the ClinicalTrials.gov page, with no evident changes to the study's details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-18T13:30:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.